AU Patent

AU2014200906B2 — Oligomer-protease inhibitor conjugates

Assigned to Nektar Therapeutics · Expires 2016-07-07 · 10y expired

What this patent protects

Abstract The invention provides protease inhibitors that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered 5 by any of a number of administration routes, exhibits characteristics that are different from the…

USPTO Abstract

Abstract The invention provides protease inhibitors that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered 5 by any of a number of administration routes, exhibits characteristics that are different from the protease inhibitors not attached to the water-soluble oligomer. 5136858 1 (GHMatters) P81855.AU.1

Drugs covered by this patent

Patent Metadata

Patent number
AU2014200906B2
Jurisdiction
AU
Classification
—
Expires
2016-07-07
Drug substance claim
No
Drug product claim
No
Assignee
Nektar Therapeutics
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.